Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mayer

Showing results (1291-1300 of 1,745) with videos related to

Pageof 175
Sort By:
Vnitrni Lekarstvi|October 26, 2012
[Our experience in treatment of multicentric plasma-cell Castleman disease associated with vasculitis manifestations - case report and literature review]P Szturz, Z Adam, M Moulis, et al.
Kidney International|May 31, 2019
Analysis from the EMPA-REG OUTCOME<sup>®</sup> trial indicates empagliflozin may assist in preventing the progression of chronic kidney disease in patients with type 2 diabetes irrespective of medications that alter intrarenal hemodynamicsGert J Mayer, Christoph Wanner, Matthew R Weir, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2001
Impact of number of nodes retrieved on outcome in patients with rectal cancerJ E Tepper, M J O'Connell, D Niedzwiecki, et al.
Cancer Treatment Reports|November 1, 1979
Phase I trial of bruceantinM B Garnick, R H Blum, G P Canellos, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Hydroxamate-based inhibitors of low affinity IgE receptor (CD23) processingS Bailey, B Bolognese, D R Buckle, et al.
Scientific Reports|March 1, 2020
First evidence of production of the lantibiotic nisin PEnriqueta Garcia-Gutierrez, Paula M O'Connor, Gerhard Saalbach, et al.
Obesity Medicine|July 10, 2018
Understanding antagonism and synergism: A qualitative assessment of weight management in youth with Type 1 diabetes mellitusAnna R Kahkoska, Madison E Watts, Kimberly A Driscoll, et al.
ESMO Open|March 12, 2024
Impact of KRAS<sup>G12</sup> mutations on survival with trifluridine/tipiracil plus bevacizumab in patients with refractory metastatic colorectal cancer: post hoc analysis of the phase III SUNLIGHT trialJ Tabernero, J Taieb, M Fakih, et al.
Cancer|July 13, 2002
A phase II trial of gemcitabine in patients with advanced hepatocellular carcinomaCharles S Fuchs, Jeffrey W Clark, David P Ryan, et al.
The Journal of Biological Chemistry|May 29, 2000
Phosphorylation of c-Crk II on the negative regulatory Tyr222 mediates nerve growth factor-induced cell spreading and morphogenesisM Escalante, J Courtney, W G Chin, et al.
Pageof 175

Showing results (1291-1300 of 1,745) with videos related to

Sort By:
Pageof 175
Vnitrni Lekarstvi|October 26, 2012
[Our experience in treatment of multicentric plasma-cell Castleman disease associated with vasculitis manifestations - case report and literature review]P Szturz, Z Adam, M Moulis, et al.
Kidney International|May 31, 2019
Analysis from the EMPA-REG OUTCOME<sup>®</sup> trial indicates empagliflozin may assist in preventing the progression of chronic kidney disease in patients with type 2 diabetes irrespective of medications that alter intrarenal hemodynamicsGert J Mayer, Christoph Wanner, Matthew R Weir, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2001
Impact of number of nodes retrieved on outcome in patients with rectal cancerJ E Tepper, M J O'Connell, D Niedzwiecki, et al.
Cancer Treatment Reports|November 1, 1979
Phase I trial of bruceantinM B Garnick, R H Blum, G P Canellos, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Hydroxamate-based inhibitors of low affinity IgE receptor (CD23) processingS Bailey, B Bolognese, D R Buckle, et al.
Scientific Reports|March 1, 2020
First evidence of production of the lantibiotic nisin PEnriqueta Garcia-Gutierrez, Paula M O'Connor, Gerhard Saalbach, et al.
Obesity Medicine|July 10, 2018
Understanding antagonism and synergism: A qualitative assessment of weight management in youth with Type 1 diabetes mellitusAnna R Kahkoska, Madison E Watts, Kimberly A Driscoll, et al.
ESMO Open|March 12, 2024
Impact of KRAS<sup>G12</sup> mutations on survival with trifluridine/tipiracil plus bevacizumab in patients with refractory metastatic colorectal cancer: post hoc analysis of the phase III SUNLIGHT trialJ Tabernero, J Taieb, M Fakih, et al.
Cancer|July 13, 2002
A phase II trial of gemcitabine in patients with advanced hepatocellular carcinomaCharles S Fuchs, Jeffrey W Clark, David P Ryan, et al.
The Journal of Biological Chemistry|May 29, 2000
Phosphorylation of c-Crk II on the negative regulatory Tyr222 mediates nerve growth factor-induced cell spreading and morphogenesisM Escalante, J Courtney, W G Chin, et al.
Pageof 175